跳至主要内容
临床试验/IRCT201307171556N53
IRCT201307171556N53已完成2 期

Efficacy of celecoxib as an adjunct in the treatment of bipolar disorder: A double blind and placebo controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • meeting the DSM-IV criteria for Bipolar Disorder; age between 18 and 65 years; a score of at least 20 points on the Young Mania Rating Scale;
  • Exclusion criteria: hyper- or hypothyroidism; substance dependence(except for Nicotine); IQ lower than 70; history of allergy to Celecoxib; lactating and pregnant women; gastro-intestinal ulcer or hemorrhage; cerebrovascular hemorrhage; severe hepatic disease

排除标准

  • 未提供

研究者

相似试验